Diabetic nephropathy

Pathogenesis and biochemical foundations

The development of renal pathology in diabetes mellitus is based on generalized diabetic microangiopathy. This process is underpinned by two fundamental mechanisms: metabolic defects and hemodynamic shifts.

Metabolic disorders are directly linked to chronic hyperglycemia and insulin deficiency. Non-enzymatic protein glycosylation plays a key role. This process leads to the excessive accumulation of advanced glycation end products, which triggers a cascade of structural changes known as glomerulopathy. At the biochemical level, an imbalance is observed: the synthesis of type IV collagen and fibronectin is sharply enhanced, whereas the production of proteoglycans (specifically heparan sulfate) is critically reduced. The outcome of the metabolic defect is a marked thickening of the glomerular basement membrane (GBM) and a pathological increase in the volume of the mesangial matrix.

Hemodynamic changes act as the second major factor hypothetically determining the development of sclerosis. They are particularly pronounced in type I diabetes mellitus. Such patients exhibit an increased glomerular filtration rate (GFR), accompanied by elevated intracapillary pressure and an increased effective filtration surface area. Constant hemodynamic overload causes compensatory glomerular hypertrophy, which subsequently becomes depleted and transforms into irreversible glomerulosclerosis in 40% of patients.

Basement membrane and diffuse sclerosis

The morphological picture of renal glomerular involvement consists of three main components. The first and earliest sign is thickening of the capillary basement membrane. This is a universal manifestation of diabetic microangiopathy, found in absolutely all patients with diabetes mellitus. It is important to note that the thickening of the membrane in itself is not associated with the development of proteinuria. True thickening can only be reliably detected using electron microscopy. Simultaneously with the glomerular capillaries, the basement membrane of the renal tubules undergoes analogous changes.

The second component is diffuse diabetic glomerulosclerosis. It is characterized by total diffuse thickening of the mesangial matrix accompanied by moderate proliferation of mesangial cells. This process always occurs against the background of pre-existing widespread GBM thickening. The pathological dynamics follow a clear sequence:

• Changes start in the vascular "pole" of the renal corpuscle, where arteriololar hyalinosis forms.
• As the disease progresses, the mesangium expands, resulting in a peculiar "entrapment" of mesangial cells by the excessive matrix.
• Gradually, sclerotic masses fill the entire volume of the glomerulus, ultimately leading to the development of severe obliterating diabetic glomerulosclerosis.

Nodular glomerulosclerosis

The third variant of involvement is nodular glomerulosclerosis, which is also known in clinical practice by the synonyms intercapillary glomerulosclerosis or Kimmelstiel-Wilson disease (Kimmelstiel P., Wilson C.). This form develops in 15–30% of patients with diabetes mellitus and is clinically always accompanied by marked renal failure.

Macroscopically and under light microscopy, the affected glomeruli acquire a characteristic oval or regular spherical shape. Due to the accumulation of dense hyaline masses along the periphery, they take on a specific laminated appearance. Pathological sclerotic nodules are localized strictly in the center of the mesangial zones of individual capillary lobules and are surrounded in a circle by preserved capillary loops.

The process is focal in nature: far from all glomeruli are involved. In those renal corpuscles or individual lobules where nodules are absent, histology frequently reveals a picture of diffuse glomerulosclerosis. Upon histochemical examination, the sclerotic nodules demonstrate a PAS-positive reaction, staining a rich red-crimson color. Their biochemical composition reliably contains lipids and fibrin threads.

Briefly: answers to topical questions

Class and exam questions

What else to study on this topic

• Mechanisms of non-enzymatic protein glycosylation
• The role of hemodynamic disorders in glomerular hypertrophy
• Electron microscopic diagnosis of basement membrane pathologies
• Differences between diffuse and nodular glomerulosclerosis
• The association of arteriolar hyalinosis with vascular "pole" involvement

Other topics in the section "Diseases of the Kidneys and Urinary Tract"

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.